Volltext-Artikel, E-Books und Literaturhinweise aus dem EBSCO Discovery Service

"Artikel & mehr" berücksichtigt nur einen Teil der für die Bibliothek der Frankfurt UAS verfügbaren Datenbanken. Zur Übersicht in DBIS

Ergebnis verändern

einschränken: Volltextzugriff; Academic (peer-reviewed) journals
erweitern: Auch Volltexte der Artikel durchsuchen; Verwandte Themen suchen

Publikationstyp

Thema

erschienen in

Verlag

Geographic terms

Sprache

Datenbank

mehr ...

Erscheinungsjahr

Von:

Bis:

Treffer 1 - 25 von 225, Suchdauer: 0.89s

12 3 4 5 6 7 8 9 weiter »

1
Immunogenicity and safety of MF59-adjuvanted H5N1 pandemic influenza vaccine in healthy infants and children: a phase 2 randomized, observer-blind, multicenter study

von Põder, Airi ; Trinidad-Aseron, Mitzi ; Van Twuijver, Esther ; et al.

In Vaccine 30 April 2026 80
- View full text via DOI
Merkliste

2
Final analysis of the ZOE-LTFU trial to 11 years post-vaccination: efficacy of the adjuvanted recombinant zoster vaccine against herpes zoster and related complications

von Strezova, Ana ; Díez Domingo, Javier ; Cunningham, Anthony L. ; et al.

In eClinicalMedicine May 2025 83
- View full text via DOI
Merkliste

3
Efficacy and safety of candidate biosimilar CT-P41 versus reference denosumab: a double-blind, randomized, active-controlled, Phase 3 trial in postmenopausal women with osteoporosis

von Reginster, Jean-Yves ; Czerwinski, Edward ; Wilk, Krzysztof ; et al.

Osteoporosis International: With other metabolic bone diseases. 35(11):1919-1930
- Zum Volltext (via ReDI)
Merkliste

4
Dieses Ergebnis aus Science Citation Index Expanded kann Gästen nicht angezeigt werden.
Login für vollen Zugriff.
- Zur Referenz in Web of Science
Merkliste

5
Dieses Ergebnis aus Science Citation Index Expanded kann Gästen nicht angezeigt werden.
Login für vollen Zugriff.
- Zur Referenz in Web of Science
Merkliste

6
Herpes zoster recurrence, and safety and immunogenicity of the recombinant zoster vaccine in adults aged ≥50 years with a history of herpes zoster: a phase 3, randomized controlled trial

von Jegede, Bisi ; Zhou, Yingjun ; Hawksworth, Helen ; et al.

In Journal of Infection August 2025
- View full text via DOI
Merkliste

7
Dieses Ergebnis aus Science Citation Index Expanded kann Gästen nicht angezeigt werden.
Login für vollen Zugriff.
- Zur Referenz in Web of Science
Merkliste

8
Immunogenicity and safety of the non-typable Haemophilus influenzae–Moraxella catarrhalis (NTHi-Mcat) vaccine administered following the recombinant zoster vaccine versus administration alone: Results from a randomized, phase 2a, non-inferiority trial

von Galgani, Ilaria ; Milleri, Stefano ; Testa, Marco ; et al.

Schlagworte: adjuvant system; AS01; chronic obstructive pulmonary disease; immune response; Moraxella catarrhalis; non-inferiority; non-typable Haemophilus influenzae; recombinant zoster vaccine; Medicina
- View full text via BASE
Merkliste

9
A Phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of V114 compared with PCV13 in healthy infants (PNEU-PED-EU-1)

von Martinon-Torres, Federico ; Wysocki, Jacek ; Szenborn, Leszek ; et al.

In Vaccine 16 May 2023 41(21):3387-3398
- View full text via DOI
Merkliste

10
Comparative efficacy and safety of biosimilar Bmab 1200 versus reference ustekinumab in moderate-to-severe plaque psoriasis: 52-week findings from the Phase 3 STELLAR-2 trial

von Szepietowski, Jacek C. ; Reich, Adam ; Feldman, Steven R. ; et al.

Expert Opinion on Biological Therapy ; volume 25, issue 10, page 1121-1133 ; ISSN 1471-2598 1744-7682
- View full text via BASE
Merkliste

11
Impact of Immunogenicity on Clinical Outcomes in Postmenopausal Women with Osteoporosis: Results from a Randomized Controlled Phase 3 Study to Compare CT-P41 (Proposed Denosumab Biosimilar) and Reference Denosumab

von Reginster, Jean-Yves ; Silverman, Stuart L. ; Czerwinski, Edward ; et al.

ACR Convergence 2024, Washington DC, United States [US], 14-19 Novembre 2024

Schlagworte: Human health sciences; Public health; health care sciences & services; Sciences de la santé humaine; Santé publique; services médicaux & soins de santé
- View full text via BASE
Merkliste

12
Prevention of influenza during mismatched seasons in older adults with an MF59-adjuvanted quadrivalent influenza vaccine: a randomised, controlled, multicentre, phase 3 efficacy study

von Beran, Jiří ; Reynales, Humberto ; Poder, Airi ; et al.

In The Lancet Infectious Diseases July 2021 21(7):1027-1037
- View full text via DOI
Merkliste

13
Dieses Ergebnis aus Science Citation Index Expanded kann Gästen nicht angezeigt werden.
Login für vollen Zugriff.
- Zur Referenz in Web of Science
Merkliste

14
Immunogenicity and safety of the non-typable Haemophilus influenzae-Moraxella catarrhalis (NTHi-Mcat) vaccine administered following the recombinant zoster vaccine versus administration alone : Results from a randomized, phase 2a, non-inferiority trial

von Galgani, Ilaria ; Poder, Airi ; Jogi, Rain ; et al.

Schlagworte: As01; Moraxella catarrhalis; Adjuvant system; Chronic obstructive pulmonary disease; Immune response; Non-inferiority; non-typable Haemophilus influenzae; Recombinant zoster vaccine; Medical biotechnology; 11832 Microbiology and virology
- View full text via BASE
Merkliste

15
Respiratory syncytial virus disease burden in community-dwelling and long-term care facility older adults in Europe and the United States : a prospective study

von Perez, Silvia Narejos ; Torrell, Josep Maria Ramon ; Poder, Airi ; et al.

2328-8957 ; Open Forum Infectious Diseases

Schlagworte: Biology; Human medicine
- View full text via BASE
Merkliste

16
Respiratory Syncytial Virus Disease Burden in Community-Dwelling and Long-Term Care Facility Older Adults in Europe and the United States: A Prospective Study

von Narejos Pérez, Sílvia ; Ramón Torrell, Josep María ; Põder, Airi ; et al.

Open Forum Infectious Diseases ; volume 10, issue 4 ; ISSN 2328-8957
- View full text via BASE
Merkliste

17
Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials

von Ahonen, Anitta ; Avelino-Silva, Thiago Junquera ; Barba-Gomez, Jose Fernando ; et al.

In Vaccine 24 April 2019 37(18):2482-2493
- View full text via DOI
Merkliste

18
Immunological non-inferiority of a new fully liquid presentation of the MenACWY-CRM vaccine to the licensed vaccine: results from a randomized, controlled, observer-blind study in adolescents and young adults

von Javier Díez-Domingo ; Juan Carlos Tinoco ; Airi Poder ; et al.

Human Vaccines & Immunotherapeutics, Vol 18, Iss 1 (2022)

Schlagworte: menacwy-crm; meningococcal serogroup a; human serum bactericidal assay; non-inferiority; adolescents; Immunologic diseases. Allergy; RC581-607; Therapeutics. Pharmacology; RM1-950
- View full text via DOI
Merkliste

19
Immunogenicity and Safety of MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared with a Nonadjuvanted, Quadrivalent Influenza Vaccine in Adults 50–64 Years of Age

von Airi Poder ; Janine Oberije ; Jay Meyer ; et al.

Vaccines, Vol 11, Iss 10, p 1528 (2023)

Schlagworte: influenza; adjuvanted influenza vaccine; chronic medical condition; age 50–64 years; middle-aged adults; Medicine
- View full text via DOI
Merkliste

20
Dieses Ergebnis aus Science Citation Index Expanded kann Gästen nicht angezeigt werden.
Login für vollen Zugriff.
- Zur Referenz in Web of Science
Merkliste

21
Immunogenicity and safety of the adjuvanted recombinant zoster vaccine co-administered with the 23-valent pneumococcal polysaccharide vaccine in adults ≥50 years of age: A randomized trial

von Maréchal, Céline ; Lal, Himal ; Poder, Airi ; et al.

In Vaccine 5 July 2018 36(29):4278-4286
- View full text via DOI
Merkliste

22
MenACWY-TT is immunogenic when co-administered with Tdap and AS04-HPV16/18 in girls and young women: Results from a phase III randomized trial

von Rivera, Luis ; Chanthavanich, Pornthep ; Põder, Airi ; et al.

In Vaccine 22 June 2018 36(27):3967-3975
- View full text via DOI
Merkliste

23
Immunogenicity, reactogenicity and safety of 2 doses of an adjuvanted herpes zoster subunit vaccine administered 2, 6 or 12 months apart in older adults: Results of a phase III, randomized, open-label, multicenter study

von Lal, Himal ; Poder, Airi ; Campora, Laura ; et al.

In Vaccine 2 January 2018 36(1):148-154
- View full text via DOI
Merkliste

24
An observer-blind, randomized, multi-center trial assessing long-term safety and immunogenicity of AS03-adjuvanted or unadjuvanted H1N1/2009 influenza vaccines in children 10–17 years of age

von Poder, Airi ; Simurka, Pavol ; Li, Ping ; et al.

In Vaccine 19 February 2014 32(9):1121-1129
- View full text via DOI
Merkliste

25
Safety profile of the adjuvanted recombinant zoster vaccine : Pooled analysis of two large randomised phase 3 trials

von López Fauqued, Marta ; Campora, Laura ; Delannois, Frédérique ; et al.

Schlagworte: Reactogenicity; Safety; Vaccine; Varicella-zoster virus
- View full text via BASE
Merkliste

12 3 4 5 6 7 8 9 weiter »

Sie haben nicht gefunden, wonach Sie gesucht haben? Diese Services können Ihnen weiterhelfen.
Hilfe & Kontakt ǀ Fernleihe | Hilfe zur Fernleihe ǀ Literaturvorschlag| Literaturvorschlag